Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Business Model:
Revenue: $39.4M
Employees: 51-200
Address: domainsbyproxy.com|14747 n northsight blvd suite 111, pmb 309
City: Scottsdale
State: AZ
Zip: 85260
Country: US
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Founded in 2010 by President Mr. Scott Shandler, Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2017 | Grant | $0 |
National Multiple Sclerosis Society (NMSS) National Multiple Sclerosis Society (NMSS) |
4/2011 | Debt Financing | $170k | 12/2013 | Grant | 1 | $155k |
National Science Foundation National Science Foundation |
4/2015 | Grant | 1 | $885.5k |
National Science Foundation National Science Foundation |
4/2012 | Grant | 2 | $350k |
Breakout Labs The Thiel Foundation Breakout Labs The Thiel Foundation |
11/2017 | Grant | 1 | $316.4k |
National Multiple Sclerosis Society (NMSS) National Multiple Sclerosis Society (NMSS) |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|